Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Harvey D. White, E. Magnus Ohman, A. Michael Lincoff, Michel E. Bertrand, Antonio Colombo, Brent T. McLaurin, David A. Cox, Stuart J. Pocock, James A. Ware, Steven V. Manoukian, Alexandra J. Lansky, Roxana Mehran, Jeffrey W. Moses, Gregg W. Stone

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences